Evaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)
A legfontosabb adatok
- Ki végzi
- University Hospital, Montpellier
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 250 fő vett részt
- Kezdés
- 2023. febr. 21.
- Befejezés
- 2024. okt. 4.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Use of flowchart
- A regiszteradat frissítve
- 2026. június 12.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 8 feltétel megnézéseKevesebb
Ki vehet részt
- Any patient who benefits from femoral TAVR regardless of the type of valve
- Age ≥ 18 years old
Ki nem vehet részt
- Patients who require CICU monitoring for a reason other than conduction disorders
- Patient refusing or unable to give consent: patient under guardianship or curator, mentally retarded, dementia, language barrier
- Patients with pacemaker or defibrillator
- Pregnant or breastfeeding women
- Patient not affiliated with an SS scheme
- Patient under judicial protection
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Considering decrease of major complications and improvement of procedural results, conductive disorders currently remain the main issue after TAVR (Transcatheter aortic valve replacement).
A teljes eredeti leírásKevesebb
While pacemaker implantation rate was about 10-15%, new onset LBBB (Left bundle branch block) was observed in 30 % of patients after TAVR but resolved at discharge in the majority of them, with less than 20% progressed to complete AV (atrioventricular) block requiring permanent pacing at hospital discharge.
Higher implantation and improvement of the devices were associated with decline of pace maker implantation rate over the years in experienced teams.
While guidelines do not give definite recommendation regarding conductive disorder management and pacemaker indication, a strategy of selective telemetry monitoring (TM) after TAVR according to the risk of conductive disorders may be proposed to limit indication and lenght of stay of intensive care unit admission (ICU), allowing direct admission of lower risk patients in general cardiology ward (GCW) without TM, to decrease the duration of TM when a conductive disorder is stable or regressive and finally to decrease the rate of pacemakers implantation.
Potential benefit may also include limitation of ICU overload in high volume TAVR centers, investigators can also expect shorter hospitalization duration, with potential economic impact, in line with the development of algorithms for fast track procedures.
Therefore the main objective of our prospective study was to evaluate feasibility and safety of a strategy of management of conductive disorders after TAVR based on an algorithm of diagnosis, monitoring and therapeutic strategies based on ECG analysis.
A vizsgálat csoportja
- Management of conductive disorders after TAVREgyéb csoport
Evaluation of efficacy and safety of a flowchart for screening, monitoring and management of conductive disorders after TAVR
Kezelés: Use of flowchart
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Evaluation and Validation of a Monitoring, Screening and Management Strategy for Conductive Disorders After TAVR (EVATAVI)
- A regiszteradat frissítve
- 2026. június 12.